SmartinBio

  • Biotech or pharma, therapeutic R&D

SmartinBio is a biotechnology company developing first-in-class mitochondrial-targeted therapeutics for resistant and relapsed acute myeloid leukemia (AML), diabetic retinopathy, Leber’s hereditary optic neuropathy (LHON), and Parkinson’s disease.

Address

Osong
South Korea

Website

http://www.smartinbio.com

Contact Exhibitor


Loading
View all Partnering Companies

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS